A Spanish survey on the use of the Aspergillus galactomannan antigen VirClia® Monotest chemiluminescent assay for the diagnosis of probable invasive aspergillosis
Enfermedades Infecciosas y Microbiología Clínica · 2026-11 · 44 (9) · 503266
DOI: 10.1016/j.eimc.2026.503266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Enfermedades Infecciosas y Microbiología Clínica, 2026-11. Verfasst von Andrea Medina und 5 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Introduction
The Aspergillus Galactomannan Antigen VirClia® Monotest (Vircell S.L., Granada, Spain) has been implemented in many laboratories in Spain; however, its use has not been clinically validated for the management of invasive pulmonary aspergillosis (IPA). Here, we gathered information on current practices related to the use of the VirClia® GM assay in Spanish hospitals.
Methods
Spanish laboratory users of the VirClia® assay were invited to respond to a standardized questionnaire.
Results
The questionnaire was completed in full by 35 out of 54 (64.8%) invited microbiology laboratories and by 14 clinicians. In addition to serum and bronchoalveolar lavages, non-validated sample types such as bronchoaspirates and endotracheal aspirates are used by around 20% of laboratories. Most laboratories (94.3%) report qualitative results using a threshold for positivity of >0.2, irrespective of the sample type and the patient's underlying condition, which is considered by most responding clinicians as a mycological criterion for probable IPA.
Conclusion
The current survey mainly reflects the heterogeneity in the use and interpretation of the VirClia® GM immunoassay, which, in the absence of clinically validated thresholds for probable IPA, introduces uncertainty and may lead to misinterpretations.
Zitieren
APA
Medina, A., Albert, E., Corrales, I., Clari, M. Á., Fernández-Cruz, A., & Navarro, D. (2026). A Spanish survey on the use of the Aspergillus galactomannan antigen VirClia® Monotest chemiluminescent assay for the diagnosis of probable invasive aspergillosis. Enfermedades Infecciosas y Microbiología Clínica, 44(9), 503266. https://doi.org/10.1016/j.eimc.2026.503266
Vancouver
Medina A, Albert E, Corrales I, Clari MÁ, Fernández-Cruz A, Navarro D. A Spanish survey on the use of the Aspergillus galactomannan antigen VirClia® Monotest chemiluminescent assay for the diagnosis of probable invasive aspergillosis. Enfermedades Infecciosas y Microbiología Clínica. 2026;44(9):503266. doi:10.1016/j.eimc.2026.503266
BibTeX
@article{Medina2026,
author = {Medina, Andrea and Albert, Eliseo and Corrales, Isabel and Clari, María Ángeles and Fernández-Cruz, Ana and Navarro, David},
title = {A Spanish survey on the use of the Aspergillus galactomannan antigen VirClia® Monotest chemiluminescent assay for the diagnosis of probable invasive aspergillosis},
journal = {Enfermedades Infecciosas y Microbiología Clínica},
year = {2026},
volume = {44},
number = {9},
pages = {503266},
doi = {10.1016/j.eimc.2026.503266}
}
EUVIMED